APA (7th ed.) Citation

GM, F., SM, A., M, R., J, C., X, L., TM, B., . . . VA, M. (2015). Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer discovery, 5(8), 850. https://doi.org/10.1158/2159-8290.CD-15-0285

Chicago Style (17th ed.) Citation

GM, Frampton, et al. "Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors." Cancer Discovery 5, no. 8 (2015): 850. https://doi.org/10.1158/2159-8290.CD-15-0285.

MLA (9th ed.) Citation

GM, Frampton, et al. "Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors." Cancer Discovery, vol. 5, no. 8, 2015, p. 850, https://doi.org/10.1158/2159-8290.CD-15-0285.